your BGIX shares are worth at least $1.50
copied from raging bull post 229 BGIX thread....
our shares are worth min 1.50 !!!!!!!!!
do not sell your shares for less then 1.50 !!!!!! read last nov news ...it clearly states that THE health
channel is doing a leveage buy out of BGIX at 1.50 per share ( BGIX was .10 then) ...
so why sell for less then 1.50..... do NOT put in stop loss at this time !!!!! ????? now that the site is
opened can we get a better buy out ?? will they give us some $$ plus shares in IPO ??
so when BGIX was .10 they made bid of $10mil to buy us out ......... we had mark-cap of 6.5mil
shares X .10= $650K ..... so they offered us 1.54 per share X 6.5mil =$10mil ?????
BGIX is worth 1.50 +++++++++++
SAN FRANCISCO--(BW HealthWire)--Nov. 19, 1998--BioLogix
International, Ltd. (OTC BB:BGIX - news), reports The Health Channelÿ is
revamping its slate of on-line commercial programs to better suit the
needs of both large advertising customers and individual consumers. At
the same time THC is said to be shaking up the roles of several of its
key producers and contractors to improve the channel's network image
and awareness.
The Health Channelÿ (THC) currently carries a demonstration
site at thehealthchannel.com, but behind the scenes has been
undertaking an extensive development of on-line healthcare programming
for both consumers and medical professionals. Under its prior purchase
by BioLogix, THC holds the right to spin-off as an independent public
company, and has recently made a tender offer to do a leveraged-buyout
of BioLogix itself; at an estimated $1.50 per share. On advice of its
underwriters the deal would allow THC to accelerate its own proposed
public offering and become more aggressive with its current
development schedule; while at the same time dramatically improving
value to the BioLogix shareholders.
Through its own and affiliate web-sites, THC is reported to be
scoring approximately 3 million ''hits'' per month on a pilot-program
basis. The channel currently offers customized personal and
professional solutions, as well as whole new ''virtual windows to the
world of healthcare.'' In anticipation of finalizing its deal with
BioLogix, THC looks to steadily build its revenues from on-line
advertising, pay-per-view and e-commerce throughout the coming year.
Although the company is said to be maintaining the secrecy of
much of its development activity, in what is becoming a highly
competitive venture capital market, more information can be obtained
at the web-site www.biologix.net and on a limited basis at
1-800/828-BGIX.
from nov 12 news
Although subject to shareholder approval, the deal appears to be
a potential windfall for both companies. Under the terms of a proposed
leveraged buy-out The Health Channelÿ would acquire approximately
$7.6 Million in assets and nearly $1 Million in revenues; both of
which are considered necessary for THC to accelerate its own proposed
registration and initial public offering (IPO). At the same time, the
BioLogix shareholders could receive a dramatically higher value for
their current investment in the form of cash and stock worth over
$1.50 per share. BioLogix is reported to have approximately 6.5
million issued and outstanding shares following completion of its
recent reorganization, and is presently traded on the over-the-counter
bulletin board market between $.10 and $.12 per share on a
''pre-filing'' basis. |
